MANZANITA PHARMACEUTICALS INC — Federal Contracts, Awards & Government Contractor Profile

About MANZANITA PHARMACEUTICALS INC

Manzanita Pharmaceuticals develops nerve imaging agents using neurotrophins conjugated with small molecule dyes for surgical guidance, with a focus on prostate cancer surgery. Their core technology involves attaching NIR dyes to rhNGF and rhBDNF for intra-operative nerve visualization.

Development of nerve imaging agents using neurotrophin-conjugated dyesIntra-operative fluorescence-guided surgery toolsCreation of small molecule drug-neurotrophin candidatesResearch and development in neurotrophic factor-based therapies

Is this your company?

Claim MANZANITA PHARMACEUTICALS INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim MANZANITA PHARMACEUTICALS INC & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.